Serotonin inhibits the influx of iron into cells by decreasing the expression of SLC11A2 in Caco-2 cells5-羟色胺通过降低SLC11A2的表达抑制Caco-2细胞中铁的流入Biomedical ReportsIF02026-01-010PRE
Relationship between circulating mitochondrial DNA and microRNA in patients with major depressionJOURNAL OF AFFECTIVE DISORDERSIF4.92023-10-0112OAAI
THE RELATIONSHIP BETWEEN CIRCULATING MITOCHONDRIAL DNA AND MIRNA IN PATIENTS WITH MAJOR DEPRESSIONEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-10-010PREAI
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depressionJOURNAL OF NEURAL TRANSMISSIONIF42019-01-0427PREAI
Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive DisorderFRONTIERS IN PSYCHIATRYIF3.22018-03-0635OAAI
Effect of HTR7 gene variants on the efficacy of second-generation antipsychotics with 5-HT7R antagonism in Japanese schizophrenia patientsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72015-09-010PREAI
Antagonist and partial agonist at the dopamine D2 receptors in drug-naive and non-drug-naive schizophrenia: a randomized, controlled trialEUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCEIF3.72015-05-287PREAI
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment responseTRANSLATIONAL PSYCHIATRYIF6.22015-04-2198OAAI
Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTsTRANSLATIONAL PSYCHIATRYIF6.22015-02-2418OAAI
Effect of the DRD2 polymorphisms on perospirone and aripiprazole efficacy for Japanese schizophrenia patients Results of an RCTEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72013-10-010PREAI
Effect of brain volume-related single nucleotide polymorphisms (SNPs) of glycogen synthase kinase 3 (GSK3)-beta gene on SSRI/SNRI treatment response in major depressive disorderEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72013-10-010PREAI
Polymorphisms of CYP2D6 Gene and Gefitinib-Induced HepatotoxicityCLINICAL LUNG CANCERIF3.32013-09-0149PRE
Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) studyINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22013-04-0129OAAI
Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depressionPSYCHIATRY RESEARCHIF3.92012-08-0120PREAI
Early partial improvement in combination with genetic variants as a predictor in major depressive disorder treatment: the result of two RCTsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72011-09-010PREAI
GENETIC POLYMORPHISMS OF CYP17A1 MAY PREDICT EARLY PROGRESSION AFTER PRIMARY ANDROGEN DEPRIVATION THERAPY IN JAPANESE MEN WITH PROSTATE CANCERJOURNAL OF UROLOGYIF6.82011-04-010PREAI
New functional variant in SLC6A4 gene as candidate of the individualised treatment of depression - the result of an RCTEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
Effect of the DRD2 Taq 1A polymorphism on perospirone and aripiprazole efficacy for Japanese schizophrenia patientsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
Simple and accurate determination of CYP2D6 gene copy number by a loop-mediated isothermal amplification method and an electrochemical DNA chipCLINICA CHIMICA ACTAIF2.92010-04-0138PREAI
Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects (vol 19, pg 718, 2009)EUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-02-010PREAI